Guillain-Barre syndrome in organ and bone marrow transplant patients.
Autor(es): Bulsara K. R.; Baron P. W.; Tuttle-Newhall J. E.; Clavien P. A.; Morgenlander J.
Resumo: Guillain-Barre Syndrome (GBS) is believed to be caused by autoimmune mechanisms that are predominantly T-cell mediated. We report GBS in organ transplant patients and bone marrow transplant patients, both of whom have iatrogenically suppressed T-cell function. We reviewed the Duke University Medical Center database from 1989-1999 for all patients who met the criteria for GBS. There were a total of 212 patients. Of these patients, two had undergone organ transplantation and two had undergone autologous bone marrow transplantation. Our report supports the notion that the humoral immune system is involved in the pathogenesis of GBS. Contrary to previous reports, however, functional recovery can occur without return of T-cell function. This suggests that in organ transplant patients, GBS may be humorally mediated and, even more importantly, responds well to treatment.
Imprenta: Transplantation, v. 71, n. 8, p. 1169-1172, 2001
Descritores: Guillain-Barre Syndrome - Cell ; Guillain-Barre Syndrome - Pathogenesis ; Guillain-Barre Syndrome - Epidemiology ; Guillain-Barre Syndrome - Immunology ; Guillain-Barre Syndrome - Public health
Data de publicação: 2001
